Manhattan Associates (MANH) Earnings Analysis
Manhattan Associates (MANH) has no confirmed upcoming earnings date. Last quarter (2026-04-21) it beat with EPS 1.24 USD vs 1.1 USD est (+12.7%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 41.30.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MANH next report earnings?
No confirmed upcoming earnings date is currently scheduled for MANH. This page updates as the calendar is published.
MANH earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-21 | 1.24 USD | 1.1 USD | +12.7% | Beat |
| 2026-01-27 | 1.21 USD | 1.11 USD | +9% | Beat |
| 2025-10-21 | 1.36 USD | 1.19 USD | +14.3% | Beat |
| 2025-07-22 | 1.31 USD | 1.13 USD | +15.9% | Beat |
| 2025-01-28 | 1.17 USD | 1.06 USD | +10.4% | Beat |
| 2024-07-23 | 1.18 USD | 0.957 USD | +23.3% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
MANH valuation and analyst view
| Trailing P/E | 41.30 |
|---|---|
| Trailing EPS | 3.63 USD |
| Price / book | 43.38 |
| Dividend yield | 0.00% |
| Market cap | 8.83B |
| Analyst consensus | Buy (11 buy / 4 hold / 0 sell) |
| Avg price target | 200 USD |
Related research pages
Frequently asked questions
When is Manhattan Associates (MANH)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for MANH. This page updates as the calendar is published.
Did MANH beat earnings last quarter?
In its 2026-04-21 report, MANH posted EPS of 1.24 USD versus a 1.1 USD estimate — a beat of 12.7%.
What is MANH's earnings track record?
Over the last 6 reported quarters with consensus data, MANH beat estimates 6 times (100%).
What is MANH's current P/E ratio and EPS?
MANH trades at a trailing P/E of 41.30 on trailing EPS of 3.6298921056158693 USD.
What do analysts rate MANH?
Analyst consensus is "Buy" across 15 ratings (0 strong buy, 11 buy, 4 hold, 0 sell, 0 strong sell). Average 12-month price target: 200 USD.